Insight SiP and its partner CYSEC, have been awarded a research and development (R&D) grant to develop an end-to-end secure communications solution for medical IoT devices. This grant is part of the Eurostars program for their MEDIcal CYbersecure NEtwork project (MEDICYNE) proposal.
As the use of IoT-based, connected healthcare objects and devices has risen, concerns about their vulnerability to cyberattacks have also increased. Examples of potential security issues include the hijacking of control of patients’ connected insulin monitoring systems or the theft of patients’ data from healthcare organizations or patients. The aim of the MEDICYNE project is to create a secure end-to-end communications solution for IoT-based IT systems between healthcare providers such as hospitals, laboratories and doctors’ surgeries and their patients. The MEDICYNE solution will provide a secure element and cryptographic processing capability in the IoT devices connected to a secure database compliant with the European Union and the USA’s Food and Drug Administration’s regulations on cybersecurity for medical data and the ability for the appropriate authorities to monitor cryptographic operations and encryption.
The MEDICYNE R&D project has a budget of €2 million, started in August 2019 and will last for 24 months. The project brings together experts in the electronics, IT and medical fields including representatives from the medical IoT industry who will form part of the project’s steering committee.
Insight SIP and CYSEC have compelling complementary skills. Insight SiP is a developer of ultra-miniature RF modules using System-in-Package (SiP) technology and CYSEC is a cybersecurity expert. Partnering with Insight SiP enables CYSEC to deploy its secure IoT solutions among multiple communication protocols and standards. Furthermore, MEDICYNE will enable the company to explore and validate the relevance of its technology in healthcare, a vertical market where privacy and secrecy are key.
The Eurostars Eureka program supports innovative research and development projects led by small- and medium-sized enterprises (SMEs) and is co-funded by Eureka Member Countries and the European Union Horizon 2020 Framework Programme.
